ArticleBioengineered2022

Matrine Combined with Mammalian Target of Rapamycin Inhibitor Enhances Anti-Tumor Efficacy of dendritic cell Vaccines in hepatocellular carcinoma.

Ning Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.